Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children

2020 ◽  
Vol 160 ◽  
pp. 108027 ◽  
Author(s):  
Xiucui Han ◽  
Pengfei Xu ◽  
Jianming Zhou ◽  
Yongxia Liu ◽  
Hui Xu
2013 ◽  
Vol 31 (4) ◽  
pp. 523-530 ◽  
Author(s):  
Fábio da Veiga Ued ◽  
Virgínia Resende S. Weffort

OBJECTIVE: To review the literature on the importance of antioxidant vitamins, analyzed in the context of dietary intake, its plasma levels, and its current use as a supplementation treatment in obese children and adolescents with nonalcoholic fatty liver disease. DATA SOURCES: The articles were identified in Lilacs, Ibecs, SciELO, PubMed/Medline, and Scopus databases. To conduct the survey, the "fatty liver" descriptor was associated to the following words: "children", "antioxidants" and "vitamins". The search was limited to articles written in Portuguese, Spanish and English, with publication date until December, 2012. DATA SYNTHESIS: Six studies were selected. The survey revealed a low dietary intake and low antioxidant vitamins serum levels in this population. The changes in lifestyle, with adequate dietary intake of vitamins, and the increase in physical activity were associated with a significant improvement in liver histology and in laboratory tests. Vitamin supplementation also improved the disease progression markers, as the alanine aminotransferase serum levels and the histological characteristics of lobular inflammation and hepatocellular damage. However, these improvements were not statistically significant in all studies. CONCLUSIONS: There is insufficient evidence to recommend or to refute antioxidant supplementation in patients with simple steatosis or steatohepatitis. The changes in lifestyle seem to be, at the present time, the more advisable therapy.


2015 ◽  
Vol 5 (4) ◽  
pp. 225-232
Author(s):  
Amal Mohamed ◽  
Maha Ghany ◽  
Hassan Shalaby ◽  
Dalal El-Melligy ◽  
Khadega Gohary ◽  
...  

2013 ◽  
Vol 29 (9) ◽  
pp. 1118-1125 ◽  
Author(s):  
Hayrullah Alp ◽  
Sevim Karaarslan ◽  
Beray Selver Eklioğlu ◽  
Mehmet Emre Atabek ◽  
Hakan Altın ◽  
...  

Hepatology ◽  
2013 ◽  
Vol 59 (2) ◽  
pp. 461-470 ◽  
Author(s):  
Lucia Pacifico ◽  
Michele Di Martino ◽  
Antonio De Merulis ◽  
Mario Bezzi ◽  
John Frederick Osborn ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-5 ◽  
Author(s):  
Dimitrios Papandreou ◽  
Mirey Karavetian ◽  
Zacharoula Karabouta ◽  
Eleni Andreou

Background. The aim of this study was to investigate the relationship between metabolic syndrome (MS) and nonalcoholic fatty liver disease (NAFLD) in obese children. One hundred and twenty-five subjects aged 11-12 years old participated in the study.Methods. Anthropometric and biochemical indices were measured, including lipid and liver profile, blood glucose, serum insulin, and liver ultrasound.Results. Forty-four children (58.6%) were found to have MS. Insulin resistance was present in 78 (62.4%) children. Patients with MS were more likely to have NAFLD (P<0.001). Children with NAFLD had significantly higher body mass index, waist circumference, triglycerides, fasting insulin, and lower high-density lipoprotein compared to patients with normal livers (P<0.001). Insulin resistance was significantly higher in children with NAFLD (P<0.001). Obese children presenting with MS were 3.01 (2.87–3.57,P<0.002) times more likely to develop NAFLD compared to those without metabolic syndrome after adjustment of cofounders.Conclusions. Obese children with MS have a higher risk of developing NAFLD. Weight management and early prevention should be the first line of treatment to prevent any possible health issues later on.


Sign in / Sign up

Export Citation Format

Share Document